Multidisciplinary management of laryngeal pathology identified in patients with COVID-19 following trans-laryngeal intubation and tracheostomy

被引:6
作者
Boggiano, Sarah [1 ,2 ]
Williams, Thomas [3 ]
Gill, Sonya E. [2 ,4 ]
Alexander, Peter D. G. [2 ,4 ,5 ]
Khwaja, Sadie [2 ,6 ]
Wallace, Sarah [1 ,2 ,4 ]
McGrath, Brendan A. [2 ,4 ,5 ]
机构
[1] Wythenshawe Hosp, Dept Speech Voice & Swallowing, Wythenshawe, England
[2] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England
[3] Univ Hosp Morecambe Bay NHS Fdn Trust, Lancaster, England
[4] Wythenshawe Hosp, Acute Intens Care Unit, Wythenshawe, England
[5] Univ Manchester, Manchester Acad Crit Care, Manchester Acad Hlth Sci Ctr, Div Infect Immun & Resp Med,Sch Biol Sci,Fac Biol, Manchester, Lancs, England
[6] Wythenshawe Hosp, Dept Head & Neck Surg, Wythenshawe, England
关键词
COVID-19; dysphagia; laryngeal pathology; tracheostomy; trans-laryngeal intubation; MECHANICAL VENTILATION; CARE;
D O I
10.1177/17511437211034699
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: COVID-19 disease often requires invasive ventilatory support. Trans-laryngeal intubation of the trachea may cause laryngeal injury, possibly compounded by coronavirus infection. Fibreoptic Endoscopic Evaluation of Swallowing (FEES) provides anatomical and functional assessment of the larynx, guiding multidisciplinary management. Our aims were to observe the nature of laryngeal abnormalities in patients with COVID-19 following prolonged trans-laryngeal intubation and tracheostomy, and to describe their impact on functional laryngeal outcomes, such as tracheostomy weaning. Methods: A retrospective observational cohort analysis was undertaken between March and December 2020, at a UK tertiary hospital. The Speech and Language Therapy team assessed patients recovering from COVID-19 with voice/swallowing problems identified following trans-laryngeal intubation or tracheostomy using FEES. Laryngeal pathology, treatments, and outcomes relating to tracheostomy and oral feeding were noted. Results: Twenty-five FEES performed on 16 patients identified a median of 3 (IQR 2-4) laryngeal abnormalities, with 63% considered clinically significant. Most common pathologies were: oedema (n = 12, 75%); abnormal movement (n = 12, 75%); atypical lesions (n = 11, 69%); and erythema (n = 6, 38%). FEES influenced management: identifying silent aspiration (88% of patients who aspirated (n = 8)), airway patency issues impacting tracheostomy weaning (n = 8, 50%), targeted dysphagia therapy (n = 7, 44%); ENT referral (n = 6, 38%) and reflux management (n = 5, 31%). Conclusions: FEES is beneficial in identifying occult pathologies and guiding management for laryngeal recovery. In our cohort, the incidence of laryngeal pathology was higher than a non-COVID-19 cohort with similar characteristics. We recommend multidisciplinary investigation and management of patients recovering from COVID-19 who required prolonged trans-laryngeal intubation and/or tracheostomy to optimise laryngeal recovery.
引用
收藏
页码:425 / 432
页数:8
相关论文
共 36 条
  • [1] Abbasi Saeed, 2018, Adv Biomed Res, V7, P154, DOI 10.4103/abr.abr_148_18
  • [2] Laryngeal complications by orotracheal intubation: Literature review
    Alves Mota, Luiz Alberto
    de Cavalho, Glauber Barbosa
    Brito, Valeska Almeida
    [J]. INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2012, 16 (02) : 236 - 245
  • [3] Laryngeal complications of endotracheal intubation
    Benjamin, Bruce
    Holinger, Lauren D.
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2008, 117 (09) : 2 - 20
  • [4] Early tracheotomy versus prolonged endotracheal intubation in unselected severely ill ICU patients
    Blot, Francois
    Similowski, Thomas
    Trouillet, Jean-Louis
    Chardon, Patrick
    Korach, Jean-Michel
    Costa, Marie-Alyette
    Journois, Didier
    Thiery, Guillaume
    Fartoukh, Muriel
    Pipien, Isabelle
    Bruder, Nicolas
    Orlikowski, David
    Tankere, Frederic
    Durand-Zaleski, Isabelle
    Auboyer, Christian
    Nitenberg, Gerard
    Holzapfel, Laurent
    Tenaillon, Alain
    Chastre, Jean
    Laplanche, Agnes
    [J]. INTENSIVE CARE MEDICINE, 2008, 34 (10) : 1779 - 1787
  • [5] Bolton L., 2020, SPEECH LANGUAGE THER, V1, P1
  • [6] Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study
    Breik, Omar
    Sharma, Neil
    Dawson, Camilla
    Bangash, Mansoor N.
    Idle, Matthew
    Isherwood, Peter
    Jennings, Christopher
    Keene, Damian
    Manji, Mav
    Martin, Tim
    Moss, Rob
    Murphy, Nick
    Parekh, Dhruv
    Parmar, Sat
    Patel, Jaimin
    Pracy, Paul
    Praveen, Prav
    Richardson, Carla
    Richter, Alex
    Sachdeva, Rajneesh
    Shields, Adrian
    Siddiq, Somiah
    Smart, Simon
    Tasker, Laura
    Nankivell, Paul
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2020, 125 (06) : 872 - 879
  • [7] Global Tracheostomy Collaborative: data-driven improvements in patient safety through multidisciplinary teamwork, standardisation, education, and patient partnership
    Brenner, Michael J.
    Pandian, Vinciya
    Milliren, Carly E.
    Graham, Dionne A.
    Zaga, Charissa
    Morriss, Linda L.
    Bedwell, Joshua R.
    Das, Preety
    Zhu, Hannah
    Allen, John Lee Y.
    Peltz, Alon
    Chin, Kimberly
    Schiff, Bradley A.
    Randall, Diane M.
    Swords, Chloe
    French, Darrin
    Ward, Erin
    Sweeney, Joanne M.
    Warrillow, Stephen J.
    Arora, Asit
    Narula, Anthony
    McGrath, Brendan A.
    Cameron, Tanis S.
    Roberson, David W.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2020, 125 (01) : E104 - E118
  • [8] Laryngeal Injury and Upper Airway Symptoms After Oral Endotracheal Intubation With Mechanical Ventilation During Critical Care: A Systematic Review*
    Brodsky, Martin B.
    Levy, Matthew J.
    Jedlanek, Erin
    Pandian, Vinciya
    Blackford, Brendan
    Price, Carrie
    Cole, Gai
    Hillel, Alexander T.
    Best, Simon R.
    Akst, Lee M.
    [J]. CRITICAL CARE MEDICINE, 2018, 46 (12) : 2010 - 2017
  • [9] Cooper RM., BENUMOF HAGBERGS AIR, V3rd, P1018
  • [10] DeLegge Mark H., 2002, Journal of Parenteral and Enteral Nutrition, V26, pS19